APA (7th ed.) Citation

B, F., A, H., & L, B. (2024). Dehydrated amniotic membrane patch for the treatment of an ocular event secondary to mirvetuximab soravtansine-gynx (MIRV) therapy. Gynecologic oncology reports, 56, 101547. https://doi.org/10.1016/j.gore.2024.101547

Chicago Style (17th ed.) Citation

B, File, Hari A, and Bei L. "Dehydrated Amniotic Membrane Patch for the Treatment of an Ocular Event Secondary to Mirvetuximab Soravtansine-gynx (MIRV) Therapy." Gynecologic Oncology Reports 56 (2024): 101547. https://doi.org/10.1016/j.gore.2024.101547.

MLA (9th ed.) Citation

B, File, et al. "Dehydrated Amniotic Membrane Patch for the Treatment of an Ocular Event Secondary to Mirvetuximab Soravtansine-gynx (MIRV) Therapy." Gynecologic Oncology Reports, vol. 56, 2024, p. 101547, https://doi.org/10.1016/j.gore.2024.101547.